检索结果-南通市图书馆

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

深圳市当代艺术馆与城市规划展览馆

城市环境设计 2020年第4期126卷 200-211页

作者：沃尔夫·狄·普瑞克斯 Jessie Castro Jessie Chen Jasmin Dieterle Luis Ferreira Peter Grell Paul Hoszowsky Dimitar Ivanov Ivana Jug Zhu Yuang Kang Alexander Karaivanov Nam La-Chi Rodelle Lee Feng Lei Megan Lepp Samuel Liew Thomas Margaretha Jens Mehlan Ivo de Nooijer Reinhard Platzl Vincenzo Possenti Pete Rose ana Santos Jutta Sch?dler Jaclyn L. Spokojny Günther Weber Chen Yue Markus Pillhofer COOP HIMMELB(L)AU Szeto Wing Duccio Malagamba ShuHe Julien Lanoo

项目大事记/CHRONOLOGY竞赛（一等奖）/Competition （1st Prize）:2007规划设计起始时间/Start of Planning:2008动工/Start of Construction:2013竣工/Completion:2016项目参数/PROJECT DATA用地面积/Site Area:21 688m2建筑毛面积/Gross Floor Area:80 000m2建筑高度-长度-宽度/Building Height-Length-Width:40m-160m-140m层数/Number of Storeys:7

关键词：

饲喂有机硒对哺乳犊牛生产性能和免疫反应的影响

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

饲料博览 2014年第11期24卷 32-32页

作者： Márcia S V S Marcus A Z Luiz C R J Fernando A S ana EC S Az Elyara M S Lúcia H F Yara M L V

研究旨在探讨在哺乳犊牛饲料中添加不同水平的硒,直接作用于皱胃时犊牛免疫系统的增强和生长性能的提高是否优于瘤胃。选用75日龄的新生犊牛(荷斯坦×新泽西州)30头,随机分配成3组:C组为对照组(不补充硒,硒源只来源于牛奶中);Se A组为皱... 详细信息

研究旨在探讨在哺乳犊牛饲料中添加不同水平的硒,直接作用于皱胃时犊牛免疫系统的增强和生长性能的提高是否优于瘤胃。选用75日龄的新生犊牛(荷斯坦×新泽西州)30头,随机分配成3组:C组为对照组(不补充硒,硒源只来源于牛奶中);Se A组为皱胃0.80 mg·头-1·d-(1注射);Se R组为瘤胃0.80 mg·头-1·d-(1口服)。犊牛在30日龄时,两个试验组犊牛血液中硒的浓度极显著高于对照组(P=0.001)。两个试验组犊牛的巨噬细胞的吞噬活性高于对照组,其中Se A组极显著高于Se R组(P=0.007)。在犊牛30日龄期间,各组间犊牛的中性粒细胞和血细胞比容的氧化活性无显著差异。30日龄Se R组的哺乳犊牛的干物质采食量(P=0.059)和胸围增益(P=0.059)均显著高于Se A组(P<0.01)。与对照组相比,补充硒可有效提高犊牛的饲料转化率(P=0.075)。30日龄各组犊牛的体增重(P=0.059)、高度和长度均无显著差异。在75日龄时,补充硒的犊牛的血液中硒含量(P=0.079)和胸围(P=0.088)呈现增加的趋势。在哺乳犊牛的牛奶中补充有机硒0.80 mg可增加血清中硒含量,并增强其30日龄时的免疫机能。对犊牛皱胃补充硒其免疫反应优于对犊牛瘤胃的补充。此外,补充硒可减少对动物生产中腹泻。补硒不能哺乳犊牛生长,但可以提高哺乳期间的免疫功能。

关键词：单核细胞矿物质中性粒细胞营养免疫系统

What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

World Journal of Nephrology 2016年第5期5卷 471-481页

作者： Pablo Molina JoséL Górriz Mariola D Molina Sandra Beltrán Belén Vizcaíno Verónica Escudero Julia Kanter ana Iávila Jordi Bover Elvira Fernández Javier Nieto Secundino Cigarrán Enrique Gruss Gema Fernández-Juárez Alberto Martínez-Castelao Juan F Navarro-González Ramón Romero Luis M Pallardó Department of Nephrology Dr Peset University Hospital46017 ValenciaSpain Department of Medicine Universitat de València46005 ValenciaSpain Department of Mathematics Universidad de AlicanteSan Vicente del Raspeig03690 AlicanteSpain Department of Nephrology FundacióPuigvert080348 BarcelonaSpain Department of Nephrology Hospital Uni-versitari de LleidaIRBlleida(Institut de Reserca Biomèdica de Lleida)25198 LleidaSpain Department of Nephrology Hospital General Universitario de Ciudad Real13005 Ciudad RealSpain Department of Nephrology Hospital da Costa Burela7880 LugoSpain Department of Nephrology Hospital Universitario Fundación Alcorcón28922 MadridSpain Department of Nephrology Hospital Universitario de BeellvitgeIDIBELLL'Hospitalet de Llobregat08907 BarcelonaSpain Research Unit and Department of Nephrology University Hospital Nuestra Senora de Candelaria38010 Santa Cruz de TenerifeSpain Department of Medicine Universitat Autònoma de Barcelona08193 BarcelonaSpain

AIM To evaluate thresholds for serum 25(OH)D concentrations in relation to death, kidney progression and hospitalization in non-dialysis chronic kidney disease(CKD) *** Four hundred and seventy non-dialysis 3-5 stage CKD patients participating in OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into 3 groups according to 25(OH)D levels at enrollment(less than 20 ng/mL, between 20 and 29 ng/mL, and at or above 30 ng/mL), considering 25(OH)D between 20 and 29 ng/mL as reference group. Association between 25(OH)D levels and death(primary outcome), and time to first hospitalization and renal progression(secondary outcomes) over a 3-year followup, were assessed by Kaplan-Meier survival curves and Cox-proportional hazard models. To identify 25(OH)D levels at highest risk for outcomes, receiver operating characteristic(ROC) curves were *** Over 29 ± 12 mo of follow-up, 46(10%) patients dead, 156(33%) showed kidney progression, and 126(27%) were hospitalized. After multivariate adjustment, 25(OH)D < 20 ng/mL was an independent predictor of all-cause mortality(HR = 2.33; 95%CI: 1.10-4.91; P = 0.027) and kidney progression(HR = 2.46; 95%CI: 1.63-3.71; P < 0.001), whereas the group with 25(OH)D at or above 30 ng/mL did not have a different hazard for outcomes from the reference group. Hospitalization outcomes were predicted by 25(OH) levels(HR = 0.98; 95%CI: 0.96-1.00; P = 0.027) in the unadjusted Cox proportional hazards model, but not after multivariate adjusting. ROC curves identified 25(OH)D levels at highest risk for death, kidney progression, and hospitalization, at 17.4 ng/mL [area under the curve(AUC) = 0.60; 95%CI: 0.685-0.69; P = 0.027], 18.6 ng/mL(AUC = 0.65; 95%CI: 0.60-0.71; P < 0.001), and 19.0 ng/m L(AUC = 0.56; 95%CI: 0.50-0.62; P = 0.048), ***25(OH)D < 20 ng/mL was an independent predictor of death and progression in patients with stage 3-5 CKD, with no addit

关键词： Vitamin D Chronic kidney disease Mortality Renal progression Hospitalization

Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Cardiology 2010年第1期2卷 13-18页

作者： Vinod Jorapur Gervasio A Lamas Zygmunt P Sadowski Harmony R Reynolds Antonio C Carvalho Christopher E Buller James M Rankin Jean Renkin Philippe Gabriel Steg Harvey D White Carlos Vozzi Eduardo Balcells Michael Ragosta C Edwin Martin Vankeepuram S Srinivas William W Wharton III Staci Abramsky ana C Mon Shari S Kronsberg Judith S Hochman Columbia University Division of Cardiology Mount Sinai Medical Center II Ischemic Heart Disease Department National Institute of Cardiology Leon Charney Division of Cardiology New York University School of Medicine Cardiology Division-Hospital Sao Paulo Federal University of Sao Paulo Division of Cardiology University of British Columbia Department of Cardiovascular Medicine Royal Perth Hospital Department of Cardiology UCL St Luc University Hospital INSERM U-698 Department of CardiologyHopital Bichat Cardiology Department Green Lane Cardiovascular ServiceAuckland City Hospital Interventional Cardiology Instituto de Intervenciones Cardiovasculares S.A. Cardiovascular Associates Wellmont Holston Valley Medical Center Cardiovascular Division University of Virginia Department of Medicine-Division of Cardiology York Hospital Division of Cardiology Montefiore Medical Center/Albert Einstein College of Medicine Research Department Asheville Cardiology AssociatesP.A. Maryland Medical Research Institute

AIM:To study if impaired renal function is associated with increased risk of peri-infarct heart failure (HF) in patients with preserved ejection fraction (EF).METHODS:Patients with occluded infarct-related arteries (IRAs) between 1 to 28 d after myocardial infarction (MI) were grouped into chronic kidney disease (CKD) stages based on estimated glomerular filtration rate (eGFR).Rates of early post-MI HF were compared among eGFR *** regression was used to explore independent predictors of ***:Reduced eGFR was present in 71.1% of 2160 patients,with significant renal impairment (eGFR anagement of peri-infarct HF.

关键词： Heart failure Myocardial infarction Kidney disease

地中海东部海区S1腐殖层的形成和保存以及生产力与降解作用的竞争

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

海洋地质 2008年第3期24卷 74-74页

作者： Gert J. De Lange Caroline Slomp Daniela Crudeli Cesare Corselli Elisabetta Erba Speranza Principato John Thomson Ivar Nijenhuis ana Ferreira Carlos Vale 陆红锋（译）陈弘（校对）荷兰乌特勒支大学米兰比可卡大学米兰大学英国Ex-SOC 埃及壳牌公司葡萄牙渔业研究所葡萄牙海洋学院不详

地中海东部海区的沉积物似乎是全球古气候变化的最佳记录媒介。独特的富含有机质的深绿色沉积物间层（腐殖质层）出现在东地中海的沉积物中，它们的出现受天文气候周期所控制，间层之间交互着缺乏有机质的沉积物层。

关键词：地中海东部降解作用海区生产力竞争保存古气候变化沉积物

Transcranial direct current electrical stimulation in combination with aerobic exercise:A pilot study in post-COVID-19 systemic autoimmune rheumatic patients

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Rheumatology 2023年第1期11卷 1-12页

作者： Rafael Giovani Missé Alexandre Moura dos Santos Isabela Bruna Pires Borges Marlise Sítima Mendes Simões Lorenza Rosa Silvério Bruna Lindoso Correia ana Wook Sook Kim Aline Marques Caetano Sandra Gofinet Pasoto Carla Gonçalves Schahin Saad Diogo Souza Domiciano Clarice Tanaka Julia Maria D’Andrea Greve Abrahão Fontes Baptista Samuel Katsuyuki Shinjo Division of Rheumatology Hospital das Clinicas HCFMUSPFaculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil Departamento de Fisioterapia Fonoaudiologia e Terapia OcupacionalHospital das Clínicas HCFMUSPFaculdade de MedicinaUniversidade de Sao PauloNúcleo de Assistência e Pesquisa em NeuromodulaçãoSao PauloBrazil Laboratório de Estudos do Movimento Instituto de Ortopedia e TraumatologiaHospital das Clinicas HCFMUSPFaculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil

BACKGROUND Systemic autoimmune rheumatic diseases(SARDs)are a group of diseases with multiorgan involvement and a high prevalence of chronic pain and *** with SARDs and post-coronavirus disease 2019(COVID-19)syndrome experience aggravation of *** this context,it is essential to establish strategies to reduce chronic pain and fatigue and improve quality of *** To assess the efficacy of transcranial direct current stimulation(tDCS)for the treatment of fatigue and pain-associated post-COVID-19 syndrome in patients with *** This study included nine patients with different types of *** patients had reverse transcription-polymerase chain reaction(RT-PCR)test confirmed COVID-19 as well as significant,persistent fatigue and pain that began to worsen after *** tDCS was administered in five daily sessions(2mA,20 min).Concomitantly,patients were involved in aerobic exercise *** participants were evaluated using specific questionnaires and strength assessment by handgrip and physical function by timed-up-and-go test and sit-to-stand test at baseline(within one week before tDCS protocol),and one week after tDCS *** all procedures,the patients’treatments remained *** The sample comprised eight women and one man with a mean age of 48.7±9.6 *** the tDCS protocol,pain and fatigue significantly improved on the visual analog scale(P<0.05).The physical function also improved 9.5±2.7 vs 6.8±0.8(P=0.001)for timed-up-go-test and 10.3±3.7 vs 15.1±4.0(P=0.037)for sit-to-stand *** of the patients experienced any adverse *** The present study showed that tDCS in combination with aerobic exercise was effective in improving physical function,and reducing fatigue/pain in SARDs patients with post-COVID-19 syndrome.

关键词： Autoimmune diseases COVID-19 Fatigue Neuromodulation Physical function Rheumatic diseases Pain

Glutamine or Glutamine Dipeptide Supplementation Improves Gluconeogenesis and Liver Glycogenosis in Type 1 Diabetic Rats

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Pharmacy and Pharmacology 2019年第7期7卷 398-407页

作者： Silvia Carla S.F.Azevedo Carlos Vinicius D.da Rosa ana Luiza M.Wunderlich Laís A.Yamada Isabela R.Mariano Camila Bataglini Nayra T.D.Branquinho Scarlett R.Raposo Roberto B.Bazotte Edmara A.Baroni Maria Raquel M.Natali Maria Montserrat D.Pedrosa Vilma A.F.de Godoi Program of Graduate Studies in Cell and Molecular Biology State University of MaringáMaringá87020-900Brazil Program of Graduate Studies in Physiological Sciences State University of MaringáMaringá87020-900Brazil Undergraduation in Biological Sciences University Center of MaringáMaringá87050-390Brazil Department of Pharmacology and Therapeutics State University of MaringáMaringá87020-900Brazil Department of Physiological Sciences State University of MaringáMaringá87020-900Brazil Department of Morphological Sciences State University of MaringáMaringá87020-900Brazil

The effects of the supplementation with L-glutamine(GLN)or L-alanyl-L-glutamine(GDP)on the progression of the systemic and hepatic metabolic status of rats having untreated type 1 diabetes mellitus(T1DM)were *** Wistar diabetic rats(streptozotocin,60 mg/kg)were allotted to four groups supplemented by gavage for thirty days as follows:control and diabetic receiving saline;diabetic receiving GLN(248 mg/kg);and diabetic receiving GDP(400 mg/kg).Body weight,plasmatic parameters and kidney function were *** hepatocytes were used to assess gluconeogenic *** and kidney were used for morphological analyses.T1DM decreased the number and increased the area of the hepatocytes,possibly because of the observed enlargement of glycogen *** weight,glomerular area and proteinuria increased,and glomerular filtration rate decreased,in non-supplemented T1DM *** area and proteinuria were reversed by both *** T1DM hepatocytes released less glucose,which could have been diverted to glycogen synthesis and secondary glycogenosis observed in T1DM;this was partially reversed by the *** results point to a possible beneficial effect of glutamine on the metabolic and hepatic impairments of T1DM.

关键词： Type 1 diabetes mellitus L-glutamine glutamine dipeptide gluconeogenesis glycogenosis

采用自体非清髓性造血干细胞移植治疗新近诊断的1型糖尿病患者

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

美国医学会杂志（中文版） 2008年第2期27卷 121-121页

作者： Jülio C. Voharelli, MD, PhD Carlos E. B. Couri, MD, PhD ana B. P. L. Stracieri, MD, PhD 谢玲玎(译) 高莹(译) 郭晓蕙(校)

背景：1型糖尿病是由细胞介导的自身免疫攻击胰岛8细胞所引起的。既往动物实验及临床研究提示，在新近诊断的1型糖尿病患者中适度给予免疫抑制可阻止胰岛素生成的减少，减少机体对胰岛素的需要量。

关键词：非清髓性造血干细胞糖尿病患移植治疗诊断自体 1型糖尿病胰岛素免疫攻击

Nat Methods:利用CRISPR-Cas9组合筛选发现癌症弱点

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

现代生物医学进展 2017年第17期17卷 I0001-I0001页

作者： John Paul Shen, ana Bojorquez-Gomez, Katherine Licon, Kristin Klepper, Daniel Pekin, Alex N Beckett, Kyle Salinas Sanchez, Jason F Kreisberg, Trey Ideker John Paul Shen, Trey Ideker, Prashant Mali John Paul Shen, Dongxin Zhao, Dan Du, Assen Roguev, Jason F Kreisberg, Nevan Krogan, Lei Qi, Trey Ideker, Prashant Mali Dongxin Zhao, Chih-Chung Kuo, Prashant Mali Roman Sasik, Amanda Birmingham, Aaron N Chang, Trey Ideker Jens Luebeck, Alex Thomas Alex Thomas, Chih-Chung Kuo, Nathan E Lewis Dan Du Assen Roguev, Nevan Krogan Nathan E Lewis Lei Qi Department of Medicine Division of Genetics University of California San Diego La Jolla California USA Moores UCSD Cancer Center La Jolla California USA The Cancer Cell Map Initiative (CCMI) La Jolla and San Francisco California USA Department of Bioengineering University of California San Diego La Jolla California USA Center for Computational Biology & Bioinformatics University of California San Diego La Jolla California USA Bioinformatics & Systems Biology Program University of California San Diego La Jolla California USA Novo Nordisk Center for Biosustainability at the University of California San Diego La Jolla California USA Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Department of Cell and Tissue Biology University of California San Francisco San Francisco California USA Department of Cellular and Molecular Pharmacology University of California San Francisco San Francisco California USA Department of Pediatrics University of California San Diego La Jolla California USA Department of Bioengineering Stanford University Stanford California USA.

导致癌症的基因突变也会削弱癌细胞，从而使得人们有机会开发选择性地杀死它们同时不影响正常细胞的药物。这一概念被称作”合成致死性（synthetic lethality）”，这是因为这些药物仅对发生突变的（或者说合成的）细胞是致命性的。在... 详细信息

导致癌症的基因突变也会削弱癌细胞，从而使得人们有机会开发选择性地杀死它们同时不影响正常细胞的药物。这一概念被称作”合成致死性（synthetic lethality）”，这是因为这些药物仅对发生突变的（或者说合成的）细胞是致命性的。在一项新的研究中。来自美国加州大学圣地亚哥分校、加州大学旧金山分校、斯坦福大学和癌细胞图谱项目（Cancer Cell Map Initiative）的研究人员开发出一种新的方法来寻找合成致死性的基因组合。

关键词：组合筛选癌症美国加州大学利用基因突变斯坦福大学癌细胞正常细胞